Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment

Fig. 3

Description of gene editing. (A) Cas9 is a protein that can induce double-stranded brakes in a target DNA (blue in the figure). Cas9 is guided at the DNA site through an RNA guide (gRNA) that has a proper 3D conformation and a complementary to a DNA sequence near a PAM motive that is different for different Cas types. (B) Architecture of TALEs. The N-terminal region of a TALE contains a type III secretion signal (T3SS) and four non-canonical repeats (NCR), the C-terminal part a transcription factor binding site (TFB), two nuclear localisation signals (NLS) and an acidic activation domain (AAD). Each TALE also contains a repeat region with a variable number of highly conserved 33-35-aa repeats arranged in tandem. The amino acid sequence of a consensus 34-aa TALE repeat is shown and the amino acids responsible for the DNA specificity of a TALE, the variable repeat di-residues (RVDs), are highlighted. The five most commonly used RVDs and the nucleotides they specify are also shown in the table. In both cases a double strand break in the target DNA sequence is induced. The cell activate repair mechanisms that cause the introduction of an insertion or a deletion at the site where the DNA was broken. If the site is in a coding sequence, the protein will not be produced because the introduction of wrong codon stops

Back to article page